HomeInsightsStock Comparison

Cohance Lifesciences Ltd vs Sigachi Industries Ltd Stock Comparison

Cohance Lifesciences Ltd vs Sigachi Industries Ltd Stock Comparison

Last Updated on: Aug 02, 2025

Key Highlights

  • The Latest Trading Price of Cohance Lifesciences Ltd is ₹ 980.4 as of 01 Aug 15:30.
  • The P/E Ratio of Cohance Lifesciences Ltd changed from 8.1 on March 2020 to 57.3 on March 2024 . This represents a CAGR of 47.89% over 5 yearsThe P/E Ratio of Sigachi Industries Ltd changed from 22.2 on March 2022 to 32.1 on March 2024 . This represents a CAGR of 13.08% over 3 years.
  • The Market Cap of Cohance Lifesciences Ltd changed from ₹ 2564 crore on March 2020 to ₹ 17223 crore on March 2024 . This represents a CAGR of 46.37% over 5 yearsThe Market Cap of Sigachi Industries Ltd changed from ₹ 888.92 crore on March 2022 to ₹ 1831 crore on March 2024 . This represents a CAGR of 27.26% over 3 years.
  • The revenue of Cohance Lifesciences Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 412.59 crore. This represent the decline of -100% The revenue of Sigachi Industries Ltd for the Jun '25 is ₹ 132.19 crore as compare to the Mar '25 revenue of ₹ 130.39 crore. This represent the growth of 1.38%.
  • The ebitda of Cohance Lifesciences Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 84.13 crore. This represent the decline of -100% The ebitda of Sigachi Industries Ltd for the Jun '25 is ₹ -92.96 crore as compare to the Mar '25 ebitda of ₹ 30.75 crore. This represent the decline of -402%.
  • The net profit of Cohance Lifesciences Ltd changed from ₹ 120.59 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The net profit of Sigachi Industries Ltd changed from ₹ 10.88 crore to ₹ -100 crore over 9 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Cohance Lifesciences Ltd changed from 23.57 % on March 2020 to 0 % on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Sigachi Industries Ltd changed from 3.76 % on March 2020 to 8 % on March 2024 . This represents a CAGR of 16.30% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Cohance Lifesciences Ltd

  • Suven Pharmaceuticals Limited (SPL) is an integrated Contract Development and Manufacturing Operations (CDMO) company that serves leading global life science and fine chemical majors.
  • The Company's comprehensive services encompass- Custom Synthesis, Process R&D, Scale-Up, and Contract Manufacturing of intermediates, APIs, and formulations. Suven Pharmaceuticals Limited was incorporated on 6 November, 2018 and is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Speciality Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies.
  • The Company has established core competencies in cyanation and heterocyclic chemistry, covering pyrimidines, quinolones, thiazoles, and imidazoles.

About Sigachi Industries Ltd

  • Sigachi Industries Limited was originally incorporated as 'Sigachi Chloro-Chemicals Private Limited' on 11 January, 1989.
  • To diversify the business activities, name of the Company was changed to 'Sigachi Industries Private Limited' on 29 March, 2012.
  • Subsequently, Company was converted from a Private Limited to a Public Limited and consequently, name was changed to 'Sigachi Industries Limited' effective on 19 December, 2019. The Company is is one of the major producer and distributor of Micro Crystalline Cellulose Powder(MCCP).
  • The Company currently offers 59 distinct grades of MCC through its two state-of-the-art manufacturing facilities in Hyderabad and Gujarat, with a total installed capacity of 11,880 MTPY. Apart from these, it is an industry leader in the field of Pharma Excipients, Nutra and food ingredients.

Cohance Lifesciences Ltd News Hub

News

Cohance Lifesciences appoints Yann D'Herve as CEO - CDMO Business

The Board of Cohance Lifesciences has appointed Yann D'Herve as Chief Executive Officer - ...

Read more

28 Jul 2025 18:56

News

Cohance Lifesciences announces resignation of CEO

Cohance Lifesciences announced the resignation of Dr. Sudhir Kumar Singh, who looks after ...

Read more

28 Jul 2025 18:52

News

Cohance Lifesciences to announce Quarterly Result

Cohance Lifesciences will hold a meeting of the Board of Directors of the Company on 13 Au...

Read more

28 Jun 2025 09:56

News

Cohance Lifesciences to hold AGM

Cohance Lifesciences announced that the 7th Annual General Meeting(AGM) of the company wil...

Read more

27 Jun 2025 15:41

News

Cohance Lifesciences' API Unit-IV clears USFDA inspection

Cohance Lifesciences has received the Establishment Inspection Report (EIR) from the Unite...

Read more

26 May 2025 08:46

News

Suven Pharmaceuticals allots 12.80 cr equity shares

Suven Pharmaceuticals has allotted 12,80,02,184 equity shares of the Company of face value...

Read more

09 May 2025 09:58

Sigachi Industries Ltd News Hub

News

Sigachi Industries reports dismal Q1 outcome

However, revenue from operations jumped 34% year on year to Rs 128.25 crore in Q1 FY26. Th...

Read more

28 Jul 2025 11:09

News

Sigachi Industries commences operations of its newly established R&D center in Hyderabad

Sigachi Industries is set to strengthen its scientific and technical capabilities with the...

Read more

23 Jul 2025 09:43

News

Sigachi Industries to hold board meeting

Sigachi Industries will hold a meeting of the Board of Directors of the Company on 25 July...

Read more

22 Jul 2025 17:33

News

Sigachi Industries receives affirmation in credit ratings from CARE

Sigachi Industries has received reaffirmation in credit rating at 'CARE A-/ CARE A2' with ...

Read more

10 Jul 2025 17:03

News

Sigachi Industries board appoints Lijo Chacko as Deputy Group CEO

Lijo Chacko is the chief executive officer ' Middle East & Africa at Sigachi Industries. H...

Read more

07 Jul 2025 13:52

News

Sigachi Industries reports fire accident at Pashamylaram, Telangana

 Sigachi Industries press release on fire accident at Hyderabad: It is with anguish that w...

Read more

02 Jul 2025 12:07

SWOT Analysis Of Cohance Lifesciences Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Sigachi Industries Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Cohance Lifesciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Sigachi Industries Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Cohance Lifesciences Ltd and Sigachi Industries Ltd

Which company has a larger market capitalization, Cohance Lifesciences Ltd or Sigachi Industries Ltd?

Market cap of Cohance Lifesciences Ltd is 37,506 Cr while Market cap of Sigachi Industries Ltd is 1,389 Cr

What are the key factors driving the stock performance of Cohance Lifesciences Ltd and Sigachi Industries Ltd?

The stock performance of Cohance Lifesciences Ltd and Sigachi Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Cohance Lifesciences Ltd and Sigachi Industries Ltd?

As of August 2, 2025, the Cohance Lifesciences Ltd stock price is INR ₹980.4. On the other hand, Sigachi Industries Ltd stock price is INR ₹36.35.

How do dividend payouts of Cohance Lifesciences Ltd and Sigachi Industries Ltd compare?

To compare the dividend payouts of Cohance Lifesciences Ltd and Sigachi Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions